ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,000 | -36.4% | 5,273 | -47.3% | 0.00% | – |
| Q1 2023 | $22,000 | -84.7% | 10,000 | -16.7% | 0.00% | – |
| Q4 2022 | $144,000 | -7.1% | 12,000 | -50.0% | 0.00% | – |
| Q3 2022 | $155,000 | +46.2% | 23,977 | +3.2% | 0.00% | – |
| Q2 2022 | $106,000 | -21.5% | 23,242 | +49.1% | 0.00% | – |
| Q1 2022 | $135,000 | -51.1% | 15,592 | -19.2% | 0.00% | – |
| Q4 2021 | $276,000 | -15.9% | 19,305 | +29.3% | 0.00% | – |
| Q3 2021 | $328,000 | +543.1% | 14,926 | +289.3% | 0.00% | – |
| Q2 2021 | $51,000 | +155.0% | 3,834 | +91.7% | 0.00% | – |
| Q1 2021 | $20,000 | +5.3% | 2,000 | -55.6% | 0.00% | – |
| Q4 2020 | $19,000 | +111.1% | 4,500 | +28.6% | 0.00% | – |
| Q3 2020 | $9,000 | -47.1% | 3,500 | -25.5% | 0.00% | – |
| Q2 2020 | $17,000 | +13.3% | 4,698 | 0.0% | 0.00% | – |
| Q1 2020 | $15,000 | -37.5% | 4,698 | +4.4% | 0.00% | – |
| Q4 2019 | $24,000 | +50.0% | 4,500 | -7.8% | 0.00% | – |
| Q3 2019 | $16,000 | +166.7% | 4,883 | +225.5% | 0.00% | – |
| Q2 2019 | $6,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +20.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -28.6% | 1,500 | -1.6% | 0.00% | – |
| Q3 2018 | $7,000 | -36.4% | 1,524 | +1.6% | 0.00% | – |
| Q2 2018 | $11,000 | +10.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2018 | $10,000 | -28.6% | 1,500 | 0.0% | 0.00% | – |
| Q4 2017 | $14,000 | +180.0% | 1,500 | +200.0% | 0.00% | – |
| Q3 2017 | $5,000 | +25.0% | 500 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | -50.0% | 500 | -28.6% | 0.00% | – |
| Q4 2015 | $6,000 | +500.0% | 700 | +250.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | -96.7% | 200 | -97.0% | 0.00% | – |
| Q4 2014 | $30,000 | +2900.0% | 6,589 | +6489.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2014 | $1,000 | -66.7% | 100 | -50.0% | 0.00% | – |
| Q4 2013 | $3,000 | +200.0% | 200 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q2 2013 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
| Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
| Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
| Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
| XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
| Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
| Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
| ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
| Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |